» Articles » PMID: 39650827

[Mapping Access to Hypertension Management Services by General Practitioners in Burkina Faso in 2020]

Overview
Journal Pan Afr Med J
Date 2024 Dec 9
PMID 39650827
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: arterial hypertension (AH) is a public health problem in Burkina Faso. Its management is not the sole responsibility of the specialist but requires the participation of all healthcare actors within a care network, with the involvement of those at the forefront. This study aimed to analyse and map the capacity for managing hypertension in Burkina Faso.

Methods: we conducted a cross-sectional online survey among general practitioners in Burkina Faso via social networks. Sampling was carried out voluntarily.

Results: our study involved 182 general practitioners with a sex ratio of 2.7: 1. The average age of the physicians was 31 years with an average professional experience of 2.7 years. The WHO minimum assessment for the management of hypertension was available for 80% of doctors and in 74% of the towns. Most physicians (96%) limited their treatment to antihypertensive dual therapy, frequently prescribing calcium channel blockers (75.8%), converting enzyme inhibitors (51.6%), and diuretics (40.7%). Specialist advice was sought in the event of uncontrolled hypertension (52.8%), with little interaction with specialists: only 20.3% of counter-referrals. Most physicians (93%) wished to participate in an AH management care network, but 98.4% needed training.

Conclusion: Burkina Faso has an uneven distribution of AH management resources. Physicians' skills need to be enhanced to improve the quality of care. Better management of resources and establishing a care network would allow better coordination of activities and improve the management of hypertension.

References
1.
Yameogo A, Mandi G, Millogo G, Samadoulougou A, Zabsonre P . Assessing causes of death in the Cardiology Department of Yalgado Ouédraogo University Hospital. Pan Afr Med J. 2015; 19:155. PMC: 4345205. DOI: 10.11604/pamj.2014.19.155.5286. View

2.
Soubeiga J, Millogo T, Bicaba B, Doulougou B, Kouanda S . Prevalence and factors associated with hypertension in Burkina Faso: a countrywide cross-sectional study. BMC Public Health. 2017; 17(1):64. PMC: 5225558. DOI: 10.1186/s12889-016-3926-8. View

3.
Kearney P, Whelton M, Reynolds K, Muntner P, Whelton P, He J . Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365(9455):217-23. DOI: 10.1016/S0140-6736(05)17741-1. View

4.
Barylski M, Malyszko J, Rysz J, Mysliwiec M, Banach M . Lipids, blood pressure, kidney - what was new in 2011?. Arch Med Sci. 2012; 7(6):1055-66. PMC: 3265000. DOI: 10.5114/aoms.2011.26620. View

5.
Banach M, Mikhailidis D, Kjeldsen S, Rysz J . Time for new indications for statins?. Med Sci Monit. 2009; 15(12):MS1-5. View